Expression and potential role of SNF5 in endometrial carcinoma

• DOI: 10.1186/s12905-019-0718-1
• Publication Date: 2019-01-25T10:02:50Z
• Authors: Shiying Sun; Yi Wu; Kai Zeng; Yue Zhao
• Keywords: Adult; 0301 basic medicine; Endometrial carcinoma; Endometrium; 03 medical and health sciences; Biomarkers, Tumor; Humans; Aged; Neoplasm Staging; p21; Gynecology and obstetrics; SMARCB1 Protein; SNF5; Middle Aged; Prognosis; Tumor progression; Immunohistochemistry; Endometrial Neoplasms; 3. Good health; Lymphatic Metastasis; RG1-991; Myometrium; Female; Public aspects of medicine; RA1-1270; Research Article

SNF5 is a key protein in regulating cell proliferation and apoptosis in various cancers. However, the physiological roles of SNF5 in Endometrial carcinoma (EC), which is one of the most frequent malignancies of the female reproduction worldwide, remains unclear. This study aims to investigate the role of SNF5 and its correlation with clinicopathologic characteristics in EC.We performed immunohistochemistry to detect the SNF5 expression in 46 endometrial carcinomas and 20 normal endometrium (non-EC) specimens, as well as analyzed the correlations between SNF5 expression and clinicopathologic features of patients using a statistics software (GraphPad Prism V6.0). Western blotting had been used to confirm the protein level of SNF5 in endometrial tissues. In addition, we evaluated the correlations between SNF5 and p21 in EC.The positive immunostaining rate for SNF5 in EC and non-EC specimens were 65% (30/46) and 25% (5/20) respectively, and the expression of SNF5 was dramatically increased in EC compared with the normal endometrium (P < 0.01). The overexpression of SNF5 was associated with the PR levels, but not with age, FIGO stage, grade, lymphatic metastasis, myometrial invasion or ER status. Knockdown of SNF5 inhibits the expression of p21.Our results indicate that SNF5 plays an important role of promoting oncogenesis in EC. These findings open up the possibility for various novel and effective combination therapies targeting SNF5 in the EC.